Geovax congratulates don diamond, ph.d. as finalist for vaccine industry excellence award at world vaccine congress

Atlanta, ga, march 15, 2023 (globe newswire) -- via newmediawire – geovax labs, inc. (nasdaq: govx), a biotechnology company developing immunotherapies and vaccines against solid tumor cancers and infectious diseases, today congratulates its colleague and collaborator, don diamond, ph.d. for recognition as a finalist for the best academic/research team award, part of the vaccine industry excellence (vie) awards to be held during the world vaccine congress in washington, dc on april 3-6, 2023.
GOVX Ratings Summary
GOVX Quant Ranking